These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 7604019)

  • 21. Defining a common region of deletion at 13q21 in human cancers.
    Chen C; Brabham WW; Stultz BG; Frierson HF; Barrett JC; Sawyers CL; Isaacs JT; Dong JT
    Genes Chromosomes Cancer; 2001 Aug; 31(4):333-44. PubMed ID: 11433524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cloning of a novel, anonymous gene from a megabase-range YAC and cosmid contig in the neurofibromatosis type 2/meningioma region on human chromosome 22q12.
    Xie YG; Han FY; Peyrard M; Ruttledge MH; Fransson I; DeJong P; Collins J; Dunham I; Nordenskjöld M; Dumanski JP
    Hum Mol Genet; 1993 Sep; 2(9):1361-8. PubMed ID: 8242058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A yeast artificial chromosome contig and NotI restriction map that spans the tumor suppressor gene(s) locus, 11q22.2-q23.3.
    Arai Y; Hosoda F; Nakayama K; Ohki M
    Genomics; 1996 Jul; 35(1):196-206. PubMed ID: 8661121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cloning and mapping of human chromosome 6q26-q27 deleted in B-cell non-Hodgkin lymphoma and multiple tumor types.
    Hauptschein RS; Gamberi B; Rao PH; Frigeri F; Scotto L; Venkatraj VS; Gaidano G; Rutner T; Edwards YH; Chaganti RS; Dalla-Favera R
    Genomics; 1998 Jun; 50(2):170-86. PubMed ID: 9653644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure and methylation-associated silencing of a gene within a homozygously deleted region of human chromosome band 8p22.
    MacGrogan D; Levy A; Bova GS; Isaacs WB; Bookstein R
    Genomics; 1996 Jul; 35(1):55-65. PubMed ID: 8661104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of CDKN2 deletions in tumor cell lines and primary glioma by interphase fluorescence in situ hybridization.
    Dreyling MH; Bohlander SK; Adeyanju MO; Olopade OI
    Cancer Res; 1995 Mar; 55(5):984-8. PubMed ID: 7867008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5'-Deoxy-5'-methylthioadenosine phosphorylase and p16INK4 deficiency in multiple tumor cell lines.
    Della Ragione F; Russo G; Oliva A; Mastropietro S; Mancini A; Borrelli A; Casero RA; Iolascon A; Zappia V
    Oncogene; 1995 Mar; 10(5):827-33. PubMed ID: 7898924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methylthioadenosine phosphorylase gene deletions are common in osteosarcoma.
    García-Castellano JM; Villanueva A; Healey JH; Sowers R; Cordon-Cardo C; Huvos A; Bertino JR; Meyers P; Gorlick R
    Clin Cancer Res; 2002 Mar; 8(3):782-7. PubMed ID: 11895909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Homozygous deletions within chromosomal bands 9p21-22 in bladder cancer.
    Stadler WM; Sherman J; Bohlander SK; Roulston D; Dreyling M; Rukstalis D; Olopade OI
    Cancer Res; 1994 Apr; 54(8):2060-3. PubMed ID: 7513608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Construction of a yeast artificial chromosome contig encompassing the human acidic fibroblast growth factor (FGF1) gene: toward the cloning of the ANLL/MDS tumor-suppressor gene.
    Chiu IM; Gilmore EC; Liu Y; Payson RA
    Genomics; 1994 Feb; 19(3):552-60. PubMed ID: 7514571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A high-resolution integrated map spanning the SDHD gene at 11q23: a 1.1-Mb BAC contig, a partial transcript map and 15 new repeat polymorphisms in a tumour-suppressor region.
    Baysal BE; Willett-Brozick JE; Taschner PE; Dauwerse JG; Devilee P; Devlin B
    Eur J Hum Genet; 2001 Feb; 9(2):121-9. PubMed ID: 11313745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequent deletion in the methylthioadenosine phosphorylase gene in T-cell acute lymphoblastic leukemia: strategies for enzyme-targeted therapy.
    Batova A; Diccianni MB; Nobori T; Vu T; Yu J; Bridgeman L; Yu AL
    Blood; 1996 Oct; 88(8):3083-90. PubMed ID: 8874207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of methylthioadenosine phosphorylase activity to select for human chromosome 9 in interspecies and intraspecies hybrid cells.
    Porterfield BW; Pomykala H; Maltepe E; Bohlander SK; Rowley JD; Diaz MO
    Somat Cell Mol Genet; 1993 Sep; 19(5):469-77. PubMed ID: 7507266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human purine nucleoside phosphorylase cDNA sequence and genomic clone characterization.
    Williams SR; Goddard JM; Martin DW
    Nucleic Acids Res; 1984 Jul; 12(14):5779-87. PubMed ID: 6087295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Localization of a putative tumor suppressor gene by using homozygous deletions in melanomas.
    Weaver-Feldhaus J; Gruis NA; Neuhausen S; Le Paslier D; Stockert E; Skolnick MH; Kamb A
    Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7563-7. PubMed ID: 8052620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detailed deletion mapping in squamous cell carcinomas of the esophagus narrows a region containing a putative tumor suppressor gene to about 200 kilobases on distal chromosome 9q.
    Miura K; Suzuki K; Tokino T; Isomura M; Inazawa J; Matsuno S; Nakamura Y
    Cancer Res; 1996 Apr; 56(7):1629-34. PubMed ID: 8603412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular characterization of 5'-deoxy-5'-methylthioadenosine phosphorylase-deficient mutant clones of murine lymphoma cell line R1.1.
    Kadariya Y; Nishioka J; Nakamura A; Kato-Nakazawa K; Nobori T
    Cancer Sci; 2003 Jun; 94(6):519-22. PubMed ID: 12824877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers.
    Nobori T; Miura K; Wu DJ; Lois A; Takabayashi K; Carson DA
    Nature; 1994 Apr; 368(6473):753-6. PubMed ID: 8152487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A 700-kb physical map of a region of 16q23.2 homozygously deleted in multiple cancers and spanning the common fragile site FRA16D.
    Paige AJ; Taylor KJ; Stewart A; Sgouros JG; Gabra H; Sellar GC; Smyth JF; Porteous DJ; Watson JE
    Cancer Res; 2000 Mar; 60(6):1690-7. PubMed ID: 10749141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure and methylation-based silencing of a gene (DBCCR1) within a candidate bladder cancer tumor suppressor region at 9q32-q33.
    Habuchi T; Luscombe M; Elder PA; Knowles MA
    Genomics; 1998 Mar; 48(3):277-88. PubMed ID: 9545632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.